Award
National Cancer Institute 5R01CA283826-03
Bioengineering adipocytes for cancer therapy
Recipient
University of California, San Francisco
Award Amount
$650,201.00
Ceiling
$650,201.00
Awarded
March 26, 2026
Identifier
5R01CA283826-03
NIH awarded a grant to University of California, San Francisco to bioengineer adipocytes for cancer therapy by enhancing their metabolic activity to suppress tumor growth.
Description
This NIH research grant focuses on engineering adipocytes and adipose organoids to increase glucose and fat utilization to out-compete tumor cells, testing therapeutic potential in cell culture and mouse cancer models.